/
Log inGet free API keyAccount
Menu
InvestorsCompaniesFit CheckerDocsPricingGet free API key

Companies / Cabaletta Bio

Cabaletta Bio

United States

Cabaletta Bio develops T cell therapies to treat autoimmune diseases

Healthcare & Biotech

Cabaletta Bio, based in United States, has 2 investors on file, among them 5AM Ventures and Boxer Capital. Its site was last checked 6 Nov 2026: site answers.

cabalettabio.com

Investors

2 investors on file
InvestorEvidenceType
5AM VenturesPortfolio pageVenture capital
Boxer CapitalPortfolio pageVenture capital

In the news

3 headlines naming Cabaletta Bio
Cabaletta Bio (NASDAQ:CABA) Stock Gets Price Target Reduction from Citigroupdailypolitical.comBrokers Issue Forecasts for Cabaletta Bio FY2030 Earningsthemarketsdaily.comWall Street Zen Upgrades Cabaletta Bio (NASDAQ:CABA) to Selltickerreport.comExit

Each headline is matched with evidence and opens on its outlet. Some come through the GDELT Project.

More from 5AM Ventures

50 companies on its checked portfolio

Its portfolio leans to Healthcare & Biotech (77%), AI & Machine Learning (11%), Fintech (4%).

Alexza PharmaceuticalsAlexza Pharmaceuticals develops and commercializes pharmaceutical prod…Aprea TherapeuticsAprea Therapeutics is a biopharmaceutical company focused on developin…Artiva BiotherapeuticsArtiva Biotherapeutics is developing therapies for autoimmune diseases…ArvinasArvinas develops targeted protein degradation therapeutics for serious…CAMP4 TherapeuticsCAMP4 Therapeutics develops RNA therapeutics to restore healthy protei…

See 5AM Ventures' full profile · Who invests alongside it

More from Boxer Capital

40 companies on its checked portfolio

Its portfolio leans to Healthcare & Biotech (90%), AI & Machine Learning (5%), Fintech (3%).

Aligos TherapeuticsAligos Therapeutics develops therapies for liver and viral diseasesAvidity BiosciencesAvidity Biosciences is developing RNA therapeutics for rare muscle dis…BioAtlaBioAtla develops novel therapeutics with improved therapeutic index th…Boundless BioBoundless Bio develops therapies for patients with intractable oncogen…Encoded TherapeuticsEncoded Therapeutics develops genetic medicines to address the root ca…

See Boxer Capital's full profile · Who invests alongside it

A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data

Free account · no card

Get Cabaletta Bio and its investors as data

Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when 5AM Ventures adds a company.

Work email, sign-in link by email. Already have an account? Log in
Your API keyRead the docs
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/companies/cabalettabio.com/investors

# also
GET /v1/companies/cabalettabio.com
GET /v1/companies/cabalettabio.com/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing